|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 53.80 INR | +2.57% |
|
-8.66% | +31.00% |
| Market Cap | 18.52B 192M 169M 157M 144M 271M 275M 1.87B 729M 9.11B 722M 706M 31.48B | P/E 2024 |
22.4x | P/E 2025 | 21.8x |
|---|---|---|---|---|---|
| Enterprise Value | 18.52B 192M 169M 157M 144M 271M 275M 1.87B 729M 9.11B 722M 706M 31.48B | EV / Sales 2024 |
1.27x | EV / Sales 2025 | 1.45x |
| Free-Float |
56.3% | Yield 2024 * |
-
| Yield 2025 | 0.42% |
| 1 day | +2.57% | ||
| 1 week | -8.66% | ||
| Current month | -9.00% | ||
| 1 month | +1.20% | ||
| 3 months | +28.95% | ||
| 6 months | +57.45% | ||
| Current year | +31.00% |
| 1 week | 51.38 |  | 58.48 |
| 1 month | 51.38 | | 64.58 |
| Current year | 33.05 | | 64.58 |
| 1 year | 33.05 | | 64.58 |
| 3 years | 29.75 | | 100.9 |
| 5 years | 23.6 | | 100.9 |
| 10 years | 7.2 | | 100.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sanjay Suri
CEO | Chief Executive Officer | 57 | 2026-06-30 |
Sushil Suri
CEO | Chief Executive Officer | 62 | 1992-01-31 |
| Director of Finance/CFO | 59 | 2002-04-02 |
| Director | Title | Age | Since |
|---|---|---|---|
Sushil Suri
CHM | Chairman | 62 | 1992-01-31 |
| Director/Board Member | 57 | 2019-08-12 | |
Savita
BRD | Director/Board Member | - | 2020-06-21 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.57% | -8.66% | - | - | 306M | |
| +0.86% | +1.43% | +47.17% | +163.68% | 1,067B | |
| +1.59% | +4.09% | +56.51% | +52.50% | 635B | |
| +0.95% | +1.91% | +36.30% | +82.78% | 458B | |
| +1.60% | +6.25% | +37.00% | +31.03% | 347B | |
| -0.60% | +1.52% | +36.67% | +41.41% | 295B | |
| -0.14% | +0.60% | +17.29% | +18.74% | 262B | |
| +0.09% | -2.82% | -29.09% | -39.57% | 216B | |
| +1.22% | +2.66% | +22.66% | +59.87% | 203B | |
| -1.18% | -3.70% | +11.28% | +67.52% | 161B | |
| Average | +0.70% | +1.33% | +26.20% | +53.11% | 404.83B | |
| Weighted average by Cap. | +0.76% | +1.95% | +35.99% | +79.10% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 17.02B 177M 155M 144M 132M 249M 253M 1.71B 670M 8.37B 663M 649M 28.93B | 18.12B 188M 165M 154M 141M 265M 269M 1.82B 713M 8.91B 706M 691M 30.79B |
| Net income | 962M 9.99M 8.77M 8.16M 7.48M 14.06M 14.28M 96.85M 37.84M 473M 37.48M 36.68M 1.63B | 1.18B 12.26M 10.76M 10.01M 9.19M 17.26M 17.53M 119M 46.44M 580M 46.01M 45.02M 2.01B |
| Net Debt | 121M 1.25M 1.1M 1.02M 938K 1.76M 1.79M 12.14M 4.74M 59.26M 4.7M 4.6M 205M | -928K -9.64K -8.46K -7.87K -7.22K -13.57K -13.78K -93.47K -36.52K -456K -36.18K -35.4K -1.58M |
Employees
1,814
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-24 | ₹53.80 | +2.57% | 6,492,856 |
| 26-07-23 | ₹52.45 | -1.41% | 6,350,338 |
| 26-07-22 | ₹53.20 | -6.37% | 8,196,539 |
| 26-07-21 | ₹56.82 | -2.42% | 5,642,616 |
| 26-07-20 | ₹58.23 | -1.14% | 4,674,638 |
- Stock Market
- Stocks
- MOREPENLAB Stock
- MOREPENLAB Stock
Select your edition
All financial news and data tailored to specific country editions
